• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Dilmapimod

CAS No. 444606-18-2

Dilmapimod ( SB-681323; GW 681323 )

产品货号. M24403 CAS No. 444606-18-2

Dilmapimod is a potent inhibitor of p38 MAPK ,it potentially suppresses inflammation in chronic obstructive pulmonary disease.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥316 有现货
10MG ¥518 有现货
25MG ¥988 有现货
50MG ¥1604 有现货
100MG ¥2989 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Dilmapimod
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    Dilmapimod is a potent inhibitor of p38 MAPK ,it potentially suppresses inflammation in chronic obstructive pulmonary disease.
  • 产品描述
    Dilmapimod is a potent inhibitor of p38 MAPK ,it potentially suppresses inflammation in chronic obstructive pulmonary disease.
  • 同义词
    SB-681323; GW 681323
  • 通路
    Autophagy
  • 靶点
    Autophagy
  • 受体
    Autophagy;p38 MAPK
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    444606-18-2
  • 分子量
    456.4
  • 分子式
    C23H19F3N4O3
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO:125 mg/mL (273.87 mM; Need ultrasonic)
  • SMILES
    Cc(cc(cc1)F)c1-c1c(C=CC(N2c(c(F)ccc3)c3F)=O)c2nc(NC(CO)CO)n1
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Singh D, et al. A randomized, placebo-controlled study of the effects of the p38 MAPK inhibitor SB-681323 on blood biomarkers of inflammation in COPD patients. J Clin Pharmacol. 2010 Jan;50(1):94-100.
产品手册
关联产品
  • SLLN-15

    SLLN-15 (Autophagy inducer SLLN-15) is a potent, orally available inducer of autophagy that selectively activated cytostatic macroautophagy/autophagy in TNBC preclinical models.

  • Alisol A

    Alisol A may be an autophagic inducer it has anti-cancer activity it presents inhibitory effects on cancer cell lines tested(HepG2 MDA-MB-231 and MCF-7 cells).

  • Mefloquine hydrochlo...

    A quinoline antimalarial drug that is structurally related to the antiarrhythmic agent quinidine; inhibits autophagy and has been recognized as a potential target for cancer therapy.